Variant report

Variant	nsv1006053
Chromosome Location	chr2:234941290-234963441
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:153)
CpG islands
(count:183)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:153 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr2:234956693-234957108	GM12878	blood:	n/a	n/a
2	BCL3	chr2:234956095-234956346	GM12878	blood:	n/a	n/a
3	BCL3	chr2:234956735-234956972	GM12878	blood:	n/a	n/a
4	CBX3	chr2:234952657-234953297	HCT-116	colon:	n/a	n/a
5	CBX3	chr2:234942615-234942944	HCT-116	colon:	n/a	n/a
6	CBX3	chr2:234942522-234942978	HCT-116	colon:	n/a	n/a
7	CEBPB	chr2:234952693-234953397	HCT-116	colon:	n/a	n/a
8	CEBPB	chr2:234947137-234947409	HepG2	liver:	n/a	chr2:234947276-234947287
9	CEBPB	chr2:234952239-234952356	HepG2	liver:	n/a	chr2:234952312-234952323
10	CEBPB	chr2:234947115-234947447	IMR90	lung:	n/a	chr2:234947276-234947287
11	CTCF	chr2:234941880-234942030	AG04450	lung:	n/a	n/a
12	CTCF	chr2:234941800-234941950	AG04450	lung:	n/a	n/a
13	CTCF	chr2:234956060-234956210	GM12868	blood:	n/a	n/a
14	CTCF	chr2:234956000-234956150	HCT-116	colon:	n/a	n/a
15	CTCF	chr2:234941660-234941810	RPTEC	kidney:	n/a	n/a
16	CTCF	chr2:234956057-234956065	ProgFib	skin:	n/a	n/a
17	CTCF	chr2:234955940-234956090	HepG2	liver:	n/a	n/a
18	CTCF	chr2:234941900-234942050	RPTEC	kidney:	n/a	n/a
19	CTCF	chr2:234956033-234956075	MCF-7	breast:	n/a	n/a
20	CTCF	chr2:234941960-234942110	HCPEpiC	choroid plexus:	n/a	n/a
21	CTCF	chr2:234956021-234956083	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr2:234941909-234942045	HUVEC	blood vessel:	n/a	n/a
23	CTCF	chr2:234941960-234942110	HMF	breast:	n/a	n/a
24	CTCF	chr2:234956080-234956230	GM12873	blood:	n/a	n/a
25	CTCF	chr2:234941920-234942070	HCPEpiC	choroid plexus:	n/a	n/a
26	CTCF	chr2:234955900-234956050	HMF	breast:	n/a	n/a
27	CTCF	chr2:234955940-234956090	MCF-7	breast:	n/a	n/a
28	CTCF	chr2:234941860-234942010	HFF-Myc	foreskin:	n/a	n/a
29	CTCF	chr2:234941860-234942010	RPTEC	kidney:	n/a	n/a
30	CTCF	chr2:234941860-234942010	HPAF	blood vessel:	n/a	n/a
31	CTCF	chr2:234956012-234956080	MCF-7	breast:	n/a	n/a
32	CTCF	chr2:234956015-234956104	K562	blood:	n/a	n/a
33	CTCF	chr2:234955940-234956090	GM12865	blood:	n/a	n/a
34	CTCF	chr2:234956030-234956082	MCF-7	breast:	n/a	n/a
35	CTCF	chr2:234955940-234956090	WERI-Rb-1	eye:	n/a	n/a
36	CTCF	chr2:234941880-234942030	HBMEC	blood vessel:	n/a	n/a
37	CTCF	chr2:234955920-234956070	WERI-Rb-1	eye:	n/a	n/a
38	CTCF	chr2:234955996-234956099	MCF-7	breast:	n/a	n/a
39	CTCF	chr2:234955977-234956093	MCF-7	breast:	n/a	n/a
40	CTCF	chr2:234955982-234956054	ProgFib	skin:	n/a	n/a
41	CTCF	chr2:234942000-234942150	BE2_C	brain:	n/a	n/a
42	CTCF	chr2:234955960-234956110	HEK293	kidney:	n/a	n/a
43	CTCF	chr2:234955958-234956132	Fibrobl	skin:	n/a	n/a
44	E2F4	chr2:234952848-234953141	MCF10A-Er-Src	breast:	n/a	n/a
45	EBF1	chr2:234941197-234941323	GM12878	blood:	n/a	chr2:234941229-234941240
46	EP300	chr2:234952614-234953406	SK-N-SH	brain:	n/a	n/a
47	EP300	chr2:234952738-234953154	SK-N-SH_RA	brain:	n/a	n/a
48	EP300	chr2:234952724-234953244	SK-N-SH	brain:	n/a	n/a
49	FOS	chr2:234940933-234941462	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr2:234956785-234957050	MCF10A-Er-Src	breast:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234959456-234959506	Hepatocyte	liver:	n/a
2	chr2:234958715-234958765	T-47D	breast:	n/a
3	chr2:234958715-234958765	SKMC	muscle:	n/a
4	chr2:234958948-234958998	NHDF-neo	bronchial:	n/a
5	chr2:234959456-234959506	SK-N-SH	brain:	n/a
6	chr2:234959456-234959506	AG09309	skin:	n/a
7	chr2:234958715-234958765	ECC-1	luminal epithelium:	n/a
8	chr2:234959456-234959506	NHBE	bronchial:	n/a
9	chr2:234958948-234958998	A549	lung:	n/a
10	chr2:234958948-234958998	SK-N-MC	brain:	n/a
11	chr2:234958948-234958998	HRPEpiC	eye:	n/a
12	chr2:234959456-234959506	T-47D	breast:	n/a
13	chr2:234959456-234959506	HCM	heart:	n/a
14	chr2:234958948-234958998	HNPCEpiC	eye:	n/a
15	chr2:234959456-234959506	NHDF-neo	bronchial:	n/a
16	chr2:234958948-234958998	AoSMC	blood vessel:	n/a
17	chr2:234959456-234959506	HCT-116	colon:	n/a
18	chr2:234959456-234959506	PrEC	prostate:	n/a
19	chr2:234958715-234958765	HRE	kidney:	n/a
20	chr2:234958715-234958765	SK-N-SH_RA	brain:	n/a
21	chr2:234958948-234958998	GM12878	blood:	n/a
22	chr2:234959456-234959506	MCF-7	breast:	n/a
23	chr2:234958715-234958765	K562	blood:	n/a
24	chr2:234958715-234958765	GM19239	blood:	n/a
25	chr2:234958948-234958998	SAEC	small airway:	n/a
26	chr2:234958715-234958765	HAEpiC	amniotic membrane:	n/a
27	chr2:234959456-234959506	BJ	skin:	n/a
28	chr2:234958715-234958765	PrEC	prostate:	n/a
29	chr2:234958715-234958765	MCF10A-Er-Src	breast:	n/a
30	chr2:234958715-234958765	HIPEpiC	eye:	n/a
31	chr2:234958948-234958998	RPTEC	kidney:	n/a
32	chr2:234958948-234958998	HL-60	blood:	n/a
33	chr2:234958715-234958765	HRPEpiC	eye:	n/a
34	chr2:234958948-234958998	NH-A	brain:	n/a
35	chr2:234958715-234958765	AG10803	skin:	n/a
36	chr2:234958715-234958765	AoSMC	blood vessel:	n/a
37	chr2:234958715-234958765	RPTEC	kidney:	n/a
38	chr2:234958715-234958765	AG04450	lung:	fetal
39	chr2:234959456-234959506	AG09319	gingival:	n/a
40	chr2:234958948-234958998	T-47D	breast:	n/a
41	chr2:234959456-234959506	AG10803	skin:	n/a
42	chr2:234959456-234959506	AG04449	skin:	fetal
43	chr2:234958948-234958998	SK-N-SH_RA	brain:	n/a
44	chr2:234958948-234958998	HCT-116	colon:	n/a
45	chr2:234959456-234959506	RPTEC	kidney:	n/a
46	chr2:234958715-234958765	HEK293	kidney:	embryo
47	chr2:234959456-234959506	ECC-1	luminal epithelium:	n/a
48	chr2:234958715-234958765	Jurkat	blood:	n/a
49	chr2:234958715-234958765	LNCaP	prostate:	n/a
50	chr2:234958948-234958998	HepG2	liver:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	2:234635414-234639782..2:234945222-234954947	Hela-S3	cervix:
2	2:234772667-234780240..2:234954947-234965240	Hela-S3	cervix:
3	chr2:234939882..234942126-chr2:234943177..234946167,2	K562	blood:
4	chr2:234958156..234959702-chr2:234961391..234963970,2	MCF-7	breast:
5	chr2:234835606..234837772-chr2:234955390..234957030,2	K562	blood:
6	chr2:234939882..234942126-chr2:234943177..234946167,2	K562	blood:
7	2:234492023-234494396..2:234954947-234965240	Hela-S3	cervix:

No data

Variant related genes	Relation type
SPP2	TF binding region
SPP2	CpG island
ENSG00000072080	chromatin interactions
ENSG00000243135	chromatin interactions
ENSG00000241635	chromatin interactions
ENSG00000224287	chromatin interactions
ENSG00000228949	chromatin interactions

Extended variants
information (count: 940 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:940 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4616477	chr2:234941290-234941291	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
2	rs182572643	chr2:234941313-234941314	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs138794631	chr2:234941366-234941367	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs528586005	chr2:234941367-234941368	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs545564425	chr2:234941379-234941380	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs149359878	chr2:234941398-234941399	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs533188917	chr2:234941404-234941405	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs549725143	chr2:234941429-234941430	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs28903977	chr2:234941461-234941462	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs569142404	chr2:234941463-234941464	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs10176886	chr2:234941470-234941471	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs28903978	chr2:234941493-234941494	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs185762833	chr2:234941516-234941517	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs565378783	chr2:234941519-234941520	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs534412884	chr2:234941530-234941531	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs190563813	chr2:234941569-234941570	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs571022959	chr2:234941586-234941587	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs537620611	chr2:234941600-234941601	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs577401875	chr2:234941693-234941694	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs144059652	chr2:234941720-234941721	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs183770879	chr2:234941723-234941724	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs545960098	chr2:234941749-234941750	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs188754656	chr2:234941786-234941787	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs147302168	chr2:234941874-234941875	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs573302198	chr2:234941901-234941902	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs556631963	chr2:234941931-234941932	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs118162921	chr2:234941982-234941983	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs140873711	chr2:234942005-234942006	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
29	rs553631093	chr2:234942007-234942008	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
30	rs144821802	chr2:234942044-234942045	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
31	rs543557531	chr2:234942059-234942060	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
32	rs563348639	chr2:234942063-234942064	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
33	rs529180003	chr2:234942087-234942088	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
34	rs75120273	chr2:234942170-234942171	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
35	rs193291915	chr2:234942176-234942177	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
36	rs565317359	chr2:234942205-234942206	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
37	rs376831150	chr2:234942213-234942214	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
38	rs528112280	chr2:234942234-234942235	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
39	rs550981986	chr2:234942244-234942245	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
40	rs150547282	chr2:234942267-234942268	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
41	rs536754476	chr2:234942299-234942300	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
42	rs551142669	chr2:234942323-234942324	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
43	rs576317794	chr2:234942365-234942366	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
44	rs536927772	chr2:234942373-234942374	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
45	rs553737713	chr2:234942393-234942394	Weak transcription Enhancers ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
46	rs183905726	chr2:234942458-234942459	Weak transcription ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
47	rs539006805	chr2:234942470-234942471	Weak transcription ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
48	rs541824414	chr2:234942488-234942489	Weak transcription ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
49	rs558996651	chr2:234942502-234942503	Weak transcription ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a
50	rs575654671	chr2:234942523-234942524	Weak transcription ZNF genes & repeats	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Wilms tumour	21544195	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD

Chromatin state (count:112 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234934800-234942400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
2	chr2:234937800-234942200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
3	chr2:234938000-234942000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
4	chr2:234939000-234942000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr2:234939000-234942200	Enhancers	Primary T killer memory cells from peripheral blood	blood
6	chr2:234939200-234941600	Enhancers	Primary T helper cells fromperipheralblood	blood
7	chr2:234939200-234941800	Enhancers	NHDF-Ad	bronchial
8	chr2:234939400-234941600	Enhancers	Osteobl	bone
9	chr2:234939400-234942200	Enhancers	Primary T helper naive cells from peripheral blood	blood
10	chr2:234939400-234942400	Enhancers	Primary T cells fromperipheralblood	blood
11	chr2:234939400-234942400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
12	chr2:234939600-234941800	Enhancers	NHEK	skin
13	chr2:234939600-234942000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
14	chr2:234939600-234942200	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
15	chr2:234939600-234942200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
16	chr2:234939800-234941800	Enhancers	Primary T helper cells PMA-I stimulated	--
17	chr2:234939800-234941800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr2:234939800-234942200	Enhancers	Muscle Satellite Cultured Cells	--
19	chr2:234939800-234942200	Enhancers	HMEC	breast
20	chr2:234940000-234941800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr2:234940000-234942000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
22	chr2:234940000-234942200	Enhancers	NH-A	brain
23	chr2:234940400-234941800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
24	chr2:234940400-234942200	Enhancers	HUVEC	blood vessel
25	chr2:234940600-234941600	Weak transcription	NHLF	lung
26	chr2:234940800-234941400	Enhancers	HSMM	muscle
27	chr2:234940800-234941600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr2:234940800-234941600	Enhancers	Primary T cells from cord blood	blood
29	chr2:234940800-234941800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
30	chr2:234940800-234941800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr2:234941600-234941800	Weak transcription	Primary T helper cells fromperipheralblood	blood
32	chr2:234941600-234941800	Enhancers	NHLF	lung
33	chr2:234941600-234942000	Flanking Active TSS	Osteobl	bone
34	chr2:234941800-234952600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr2:234942000-234942200	Enhancers	Osteobl	bone
36	chr2:234942000-234943400	ZNF genes & repeats	Primary T helper memory cells from peripheral blood 1	blood
37	chr2:234942200-234943800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
38	chr2:234942200-234945000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr2:234943400-234946200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
40	chr2:234943800-234944000	Enhancers	Pancreas	Pancrea
41	chr2:234943800-234944800	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr2:234943800-234944800	ZNF genes & repeats	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr2:234944000-234944800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
44	chr2:234944000-234946200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr2:234944400-234944600	ZNF genes & repeats	Aorta	Aorta
46	chr2:234944400-234944600	ZNF genes & repeats	Pancreas	Pancrea
47	chr2:234946200-234947400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr2:234946800-234947400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr2:234946800-234947400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr2:234947000-234947400	Enhancers	HSMM	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links